Pharmacological treatment with memantine of oscilloscopy in patients suffering from multiple sclerosis: randomized,double blind placebo controlled study. - ND

OSPEDALE S. RAFFAELE0 个研究点目标入组 40 人开始时间: 2008年3月20日最近更新: 2021年10月26日

适应症

试验速览

暂无简介。

•male or female aged 18-60 yrs
•diagnosis of Multiple Sclerosis (any course of disease)
•presence of nystagmus associated with oscillopsy (as reported by the patient)
•no MS relapse within the last 3 months and/or deterioration of >1.0 at EDSS scale in the last 6 months prior to enrolment
•Oscillopsy is present at least for 25% of daytime as assessed with specific ordinal questionary for patients
•Visual Acuity greater than 2/10 in the worst eye
•Patients have signed the informed consent form to participate the study
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•current treatment with GABAergic drugs from at least 30 days prior to baseline visit
•involvement in any other experimental pharmacological treatment in the previous 3 months
•clinical history of epilepsy, Coronaric Heart Disease, pregnancy, uncontrolled hypertension, moderate renal failure

发起方

OSPEDALE S. RAFFAELE